title: Biosimilars and drug development in allergic and immunologic diseases.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Campania Luigi Vanvitelli (previously Second University of Naples), Naples, Italy; Italian National Research Council, Institute of Translational Pharmacology, Rome, Italy; Expert-on-Secondment, European Medicines Agency, London, United Kingdom. Electronic address: se.bonini@gmail.com.
authors.forename: Sergio
authors.initials: S
authors.lastname: Bonini
authors.affiliation: National Heart and Lung Institute (NHLI), Imperial College London, London, United Kingdom; Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Rome, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Bonini
mesh_terms: D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001688:Biological Products / Q000191:economics / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000191:economics / Q000627:therapeutic use*; D000076722:Drug Development; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000453:epidemiology; D007154:Immune System Diseases / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
chemical_list: D018926:Anti-Allergic Agents; D018501:Antirheumatic Agents; D001688:Biological Products; D059451:Biosimilar Pharmaceuticals; D016568:Drugs, Generic
keywords: Allergic; biologics